Medreich Limited — Fexofenadine Exporter Profile
Indian Pharmaceutical Exporter · #7 for Fexofenadine · $5.7M export value · DGFT Verified
Medreich Limited is the #7 Indian exporter of Fexofenadine with $5.7M in export value and 163 verified shipments. Medreich Limited holds a 5.2% market share in Fexofenadine exports across 6 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Fexofenadine Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Fexofenadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $1.6M | 95 | 38.3% |
| UNITED KINGDOM | $1.5M | 33 | 35.0% |
| NETHERLANDS | $573.0K | 15 | 13.6% |
| IRELAND | $359.6K | 10 | 8.5% |
| NEW ZEALAND | $148.2K | 7 | 3.5% |
| SINGAPORE | $45.3K | 3 | 1.1% |
Medreich Limited exports Fexofenadine to 6 countries. The largest destination is AUSTRALIA accounting for 38.3% of Medreich Limited's Fexofenadine shipments, followed by UNITED KINGDOM (35.0%) and NETHERLANDS (13.6%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fexofenadine from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDREICH PLC | UNITED KINGDOM | $1.5M | 33 |
| MEDREICH AUSTRALIA PTY LTD | AUSTRALIA | $1.3M | 75 |
| AMAROX PHARMA B.V. | NETHERLANDS | $268.5K | 6 |
| AMAROX PHARMA B.V | NETHERLANDS | $218.5K | 7 |
| MYLAN AUSTRALIA PTY LIMITED | AUSTRALIA | $218.4K | 9 |
| AZURE PHARMACETICALS | IRELAND | $154.2K | 4 |
| MEDREICH AUSTRALIA PTY LIMITED | AUSTRALIA | $126.6K | 11 |
| AZURE PHARMACEUTICALS. | IRELAND | $124.2K | 3 |
| AFT PHARMACEUTICALS LTD | NEW ZEALAND | $117.7K | 4 |
| AZURE PHARMACEUTICALS | IRELAND | $81.2K | 3 |
Medreich Limited supplies Fexofenadine to 15 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by MEDREICH AUSTRALIA PTY LTD (AUSTRALIA) and AMAROX PHARMA B.V. (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fexofenadine Export Value and How Much Does Medreich Limited Contribute?
India exported $81.9M worth of Fexofenadine through 4,236 shipments from 224 suppliers to 97 countries, serving 599 buyers globally. Medreich Limited contributes $5.7M to this total, accounting for 5.2% of India's Fexofenadine exports. Medreich Limited ships Fexofenadine to 6 countries through 15 buyers.
What Is the Average Shipment Value for Medreich Limited's Fexofenadine Exports?
Medreich Limited's average Fexofenadine shipment value is $34.8K per consignment, based on 163 shipments totaling $5.7M. The largest destination is AUSTRALIA (38.3% of Medreich Limited's Fexofenadine exports).
How Does Medreich Limited Compare to Other Indian Fexofenadine Exporters?
Medreich Limited ranks #7 among 224 Indian Fexofenadine exporters with a 5.2% market share. The top 3 exporters are IND SWIFT LIMITED ($14.6M), CIPLA LIMITED ($13.6M), DR.REDDY'S LABORATORIES LTD ($12.4M). Medreich Limited processed 163 shipments to 6 destination countries.
What Fexofenadine Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FEXOFENADINE HYDROCHLORIDE TABLETS 180MG | $1.0M | 31 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM CO | $250.0K | 5 |
| FEXOFENADINE HYDROCHLORIDE TABLETS 120MG | $183.9K | 5 |
| FEXOFENADINE HCL 180MG FILM COATED TABLETS (FEXOFENADINE HCL AMAROX 180MG TABLETS) 3X10S(134316 PACKS) | $150.0K | 3 |
| FEXOFENADINE HYDROCHLORIDE 180MG TABS ( | $139.5K | 5 |
| FEXOFENADINE HYDROCHLORIDE TABLETS 180 M | $112.5K | 3 |
| FEXOFENADINE HYDROCHLORIDE TABLETS 120MG3X10S (100008 PACKS) | $92.2K | 3 |
| FEXOFENADINE HYDROCHLORIDE 180MG TABLETSXERGIC 180 6X10S 11610 PACKS | $83.4K | 2 |
| FEXOFENADINE HYDROCHLORIDE 180MGTABLETS | $82.2K | 3 |
| FEXOFENADINE HYDROCHLORIDE 180MG TABLETS | $80.9K | 7 |
Medreich Limited exports 89 distinct Fexofenadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEXOFENADINE HYDROCHLORIDE TABLETS 180MG with 31 shipments worth $1.0M.
Regulatory Requirements: Exporting Fexofenadine to Key Markets
What Medreich Limited must comply with to export Fexofenadine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medreich Limited Compare to Nearest Fexofenadine Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED | $9.7M | 194 | 1 | $50.0K |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.7M | 154 | 7 | $50.0K |
| 7 | MEDREICH LIMITED ★ | $5.7M | 163 | 6 | $34.8K |
| 8 | LYRUS LIFE SCIENCES PRIVATE LIMITED | $3.4M | 68 | 1 | $50.0K |
| 6 | DR REDDYS LABORATORIES LIMITED | $3.1M | 62 | 3 | $50.0K |
Medreich Limited ranks #7 among 224 Indian Fexofenadine exporters. Average shipment value of $34.8K compared to the market average of $365.5K. The closest competitors by value are GRANULES INDIA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Fexofenadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 569 | 13.4% |
| JNPT/ NHAVA SHEVA SEA | 385 | 9.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 362 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 350 | 8.3% |
| HYDERABAD ICD | 229 | 5.4% |
| CHAWAPAYAL ICD | 186 | 4.4% |
| JNPT | 161 | 3.8% |
| CHAWAPAYAL ICD (INCPR6) | 142 | 3.4% |
What Other Antihistamines & Allergy Products Does Medreich Limited Export?
Medreich Limited also exports these antihistamines & allergy products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medreich Limited's Fexofenadine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Fexofenadine, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fexofenadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 163 individual customs records matching Medreich Limited exporting Fexofenadine, covering 89 formulations to 6 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 599+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fexofenadine Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Fexofenadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Fexofenadine Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fexofenadine. For current shipment-level data, contact TransData Nexus.